This inventor holds 1 USPTO granted patent. Top assignee: Onyx Pharmaceuticals, Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Jerry Yuqiao Shen: Innovator in Oncolytic Adenovirus Research
Introduction
Jerry Yuqiao Shen is a prominent inventor based in Orinda, California. He has made significant contributions to the field of biotechnology, particularly in the development of oncolytic adenoviruses. His innovative work focuses on creating viral vectors that selectively target and kill cancerous cells while sparing normal cells.
Latest Patents
Jerry Yuqiao Shen holds a patent for an oncolytic adenovirus. This patent describes viral vectors and methods for producing these vectors that preferentially eliminate neoplastic cells. The preferred vector is an adenovirus that incorporates tumor-specific promoters, particularly those responsive to E2F, in the E1A and/or E4 regions.
Career Highlights
Jerry is currently employed at Onyx Pharmaceuticals, Inc., where he continues to advance his research in cancer therapeutics. His work has the potential to revolutionize cancer treatment by providing more effective and targeted therapies.
Collaborations
Throughout his career, Jerry has collaborated with notable colleagues, including Leisa Johnson and Ali Fattaey. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jerry Yuqiao Shen is a key figure in the field of oncolytic adenovirus research, with a focus on developing targeted cancer therapies. His contributions are paving the way for advancements in cancer treatment and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile